Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,977 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
Taniguchi H, Nakamura Y, Kotani D, Yukami H, Mishima S, Sawada K, Shirasu H, Ebi H, Yamanaka T, Aleshin A, Billings PR, Rabinowitz M, Oki E, Takemasa I, Kato T, Mori M, Yoshino T. Taniguchi H, et al. Among authors: mori m. Cancer Sci. 2021 Jul;112(7):2915-2920. doi: 10.1111/cas.14926. Epub 2021 Jun 7. Cancer Sci. 2021. PMID: 33931919 Free PMC article. Clinical Trial.
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
Miyo M, Kato T, Nakamura Y, Taniguchi H, Takahashi Y, Ishii M, Okita K, Ando K, Yukami H, Mishima S, Yamazaki K, Kotaka M, Watanabe J, Oba K, Aleshin A, Billings PR, Rabinowitz M, Kotani D, Oki E, Takemasa I, Mori M, Yoshino T. Miyo M, et al. Among authors: mori m. Cancer Sci. 2022 Apr;113(4):1531-1534. doi: 10.1111/cas.15226. Epub 2022 Feb 28. Cancer Sci. 2022. PMID: 34839585 Free PMC article.
Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first-line treatment.
Fujimoto Y, Oki E, Qiu S, Nakanishi R, Makiyama A, Miyamoto Y, Kotaka M, Shimokawa M, Ando K, Kimura Y, Kitao H, Maehara Y, Mori M. Fujimoto Y, et al. Among authors: mori m. Cancer Sci. 2021 Jun;112(6):2436-2441. doi: 10.1111/cas.14904. Epub 2021 May 3. Cancer Sci. 2021. PMID: 33780084 Free PMC article. Clinical Trial.
Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.
Hamabe A, Yamamoto H, Konno M, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Nishida N, Kawamoto K, Koseki J, Doki Y, Mori M, Ishii H. Hamabe A, et al. Among authors: mori m. Cancer Sci. 2014 Sep;105(9):1100-8. doi: 10.1111/cas.12487. Epub 2014 Sep 16. Cancer Sci. 2014. PMID: 25060325 Free PMC article.
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
Satake H, Ando K, Oki E, Shimokawa M, Makiyama A, Saeki H, Tsuji A, Mori M. Satake H, et al. Among authors: mori m. BMC Cancer. 2020 Nov 17;20(1):1116. doi: 10.1186/s12885-020-07576-9. BMC Cancer. 2020. PMID: 33203393 Free PMC article.
Trifluridine/tipiracil plus bevacizumab as a first-line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial.
Oki E, Makiyama A, Miyamoto Y, Kotaka M, Kawanaka H, Miwa K, Kabashima A, Noguchi T, Yuge K, Kashiwada T, Ando K, Shimokawa M, Saeki H, Akagi Y, Baba H, Maehara Y, Mori M. Oki E, et al. Among authors: mori m. Cancer Med. 2021 Jan;10(2):454-461. doi: 10.1002/cam4.3618. Epub 2020 Nov 29. Cancer Med. 2021. PMID: 33249761 Free PMC article. Clinical Trial.
9,977 results